SEARCH

SEARCH BY CITATION

References

  • 1
    Orlando RC. Reflux esophagitis: an overview. Scand J Gastroenterol 1995; 210: 367.
  • 2
    Locke GR III, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ III. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997; 112: 144856.
  • 3
    Nebel OT, Fornes MF, Castell DO. Symptomatic gastroesophageal reflux: incidence and precipitating factors. Dig Dis 1976; 21: 9536.
  • 4
    Jaroff L. Fire in the belly, money in the bank. TIME Magazine 1995; 146.
  • 5
    Marks RD, Richter JE. Peptic strictures of the esophagus. Am J Gastroenterol 1993; 88: 116073.
  • 6
    Spechler SJ, Goyal RK. The columnar lined esophagus, intestinal metaplasia, and Norman Barrett. Gastroenterology 1996; 110: 61421.
  • 7
    Lagergren J, Bergström R, Lindgren A, Nyrén O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999; 340: 82531.
  • 8
    Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998; 83: 204953.
  • 9
    Sonnenberg A, Massey BT, Jacobsen SJ. Hospital discharges resulting from esophagitis among medicare beneficiaries. Dig Dis Sci 1994; 39: 1838.
  • 10
    Ho KY, Kang JY, Seow A. Prevalence of gastrointestinal symptoms in a multiracial Asian population, with particular reference to reflux-type symptoms. Am J Gastroenterol 1998; 93: 181622.
    Direct Link:
  • 11
    Chang CS, Poon SK, Lien HC, Chen GH. The incidence of reflux esophagitis among the Chinese. Am J Gastroenterol 1997; 92: 66871.
  • 12
    Cameron AJ. Epidemiology of columnar-lined esophagus and adenocarcinoma. Gastroenterol Clin N Am 1997; 26: 48794.
  • 13
    Mayer RJ. Overview: the changing nature of esophageal cancer. Chest 1993; 103: 404S5S.
  • 14
    Blot WJ, Devesa SS, Fraumeni JF Jr. Continuing climb in rates of esophageal adenocarcinoma: an update. J Am Med Assoc 1993; 270: 1320.
  • 15
    Blot WJ. Esophageal cancer trends and risk factors. Semin Oncol 1994; 21: 40310.
  • 16
    Cheng KK. The etiology of esophageal cancer in Chinese. Semin Oncol 1994; 21: 4115.
  • 17
    Yeh C, Hsu CT, Ho AS, Sampliner RE, Fass R. Erosive esophagitis and Barrett's esophagus in Taiwan. A higher frequency than expected. Dig Dis Sci 1997; 42: 7026.
  • 18
    Lundell LR, Dent J, Bennett JR, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999; 45: 17280.
  • 19
    Parsonnet J. The incidence of Helicobacter pylori infection. Aliment Pharmacol Ther 1995; 9(Suppl. 2): 4551.
  • 20
    Werdmuller BFM, Loffeld RJLF. Helicobacter pylori infection has no role in the pathogenesis of reflux esophagitis. Dig Dis Sci 1997; 42: 1035.
  • 21
    Labenz J, Blum AL, Bayerdörffer E, Meining A, Stolte M, Börsch G. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 1997; 112: 14427.
  • 22
    Chow WH, Blaser MJ, Blot WJ, et al. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res 1998; 58: 58890.
  • 23
    Vicari JJ, Peek RM, Falk GW, et al. The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology 1998; 115: 507.
  • 24
    Graham DY, Yamaoka Y. H. pylori and cagA: relationships with gastric cancer, duodenal ulcer, and reflux esophagitis and its complications. Helicobacter 1998; 3: 14550.
  • 25
    Cheng FC, Lam SK, Ong GB. Maximum acid output to graded doses of pentagastrin and its relation to parietal cell mass in Chinese patients with duodenal ulcer. Gut 1977; 18: 82732.
  • 26
    DeVault KR, Castell DO. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol 1999; 94: 143442.
    Direct Link:
  • 27
    Eckardt VF, Kanzler G, Bernhard G. Life expectancy and cancer risk in patients with Barrett's esophagus: a prospective controlled investigation. Am J Med 2001; 111: 337.
  • 28
    Van der Burgh A, Dees J, Hop WCJ, Van Blankenstein M. Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus. Gut 1996; 39: 58.
  • 29
    Spechler SJ. Barrett's esophagus: Should we brush off this ballooning problem? Gastroenterology 1997; 112: 213842.